Literature DB >> 3373568

Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus.

D A Hendricks1, K McIntosh, J L Patterson.   

Abstract

A soluble form of the G glycoprotein, the attachment protein, of respiratory syncytial virus is shed from infected HEp-2 cells. The Gs proteins of the Long and 18537 strains have apparent molecular sizes of 82 and 71 kilodaltons, respectively, 6 to 9 kilodaltons smaller than the virion-associated forms (Gv). The Gs protein of the Long strain was further characterized. Approximately one in six of all of the radiolabeled G molecules in these cultures at 24 h postinfection was present as the Gs protein. The Gs protein was clearly evident in culture fluids at 6 h postinfection, but the Gv protein could not be discerned until 12 h after infection, an observation that is consistent with the 12-h eclipse period for respiratory syncytial virus. Therefore, the Gs protein is shed, in part at least, from intact, infected cells and before the appearance of progeny virus. The appearance of a smaller Gs protein (74 kilodaltons) in fluids of infected calls which were incubated with tunicamycin shows that addition of N-linked oligosaccharides is not required for the genesis and shedding of the Gs protein. Sequencing of the amino terminus of purified Gs protein revealed two different termini, whose generations are consistent with cleavages of the full-length G protein between amino acids 65 and 66 and between residues 74 and 75. This result suggests that the Gs protein is present in two different forms which lack the proposed intracytoplasmic and transmembrane domains of the full-length G protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373568      PMCID: PMC253358     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis.

Authors:  A B Chen; T Ben-Porat; R J Whitley; A S Kaplan
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

2.  Synthesis and distribution of vesicular stomatitis virus-specific polypeptides in the absence of progeny production.

Authors:  S P Little; A S Huang
Journal:  Virology       Date:  1977-08       Impact factor: 3.616

3.  Oncornavirus envelope glycoprotein in serum of mice.

Authors:  M Strand; J T August
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

4.  Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus.

Authors:  S Levine; R Klaiber-Franco; P R Paradiso
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

Review 5.  Biological applications of ionophores.

Authors:  B C Pressman
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

6.  Structure of the glycoprotein gene in rabies virus.

Authors:  A Anilionis; W H Wunner; P J Curtis
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

7.  Paramyxovirdae.

Authors: 
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

8.  Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion.

Authors:  B F Fernie; J L Gerin
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Sequence of the influenza A/Udorn/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA.

Authors:  L Markoff; C J Lai
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

10.  Structure of the neuraminidase gene in human influenza virus A/PR/8/34.

Authors:  S Fields; G Winter; G G Brownlee
Journal:  Nature       Date:  1981-03-19       Impact factor: 49.962

View more
  39 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

Review 3.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

Review 4.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 5.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 6.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

Review 7.  Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Authors:  José A Melero; Vicente Mas; Jason S McLellan
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

8.  The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons.

Authors:  S R Roberts; D Lichtenstein; L A Ball; G W Wertz
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats.

Authors:  Myra N Widjojoatmodjo; Jolande Boes; Marleen van Bers; Yvonne van Remmerden; Paul J M Roholl; Willem Luytjes
Journal:  Virol J       Date:  2010-06-02       Impact factor: 4.099

Review 10.  Structure and function of respiratory syncytial virus surface glycoproteins.

Authors:  Jason S McLellan; William C Ray; Mark E Peeples
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.